XOMAO

Conviction 27HealthcareScan · Thu, Jun 25, 2026

XOMAO$25.44+0.04%

ResistanceSupportVol 14

Vol MA14 5.34K

Mar 25Apr 13Apr 30May 18Jun 5Jun 24

XOMA Royalty CorpPHARMACEUTICAL PREPARATIONSwww.xoma.com ↗

Price25.44

Change+0.04%

Gap+0.04%

Rel volume0.76×

Avg volume4.7K

Avg $ vol119.13K

SMA 2024.12

SMA 5024.86

SMA 20025.18

Price vs 50+2.34%

Price vs 200+1.05%

MA stackmixed

50/200 crossdeath · 8d

Supertrendup · 18.40

RSI (14)52

MACD hist0.40

MACD crossbull · 4d

Stoch %K / %D100 / 100

ADX (14)14

+DI / −DI51 / 47

RSI divergence—

MACD divergenceBearish

ATR %+8.39%

ADR %0.13%

52w high26.25

52w low0.0000

From 52w high-3.07%

Above 52w low—

New 52w highNo

SqueezeOff

Bollinger width91.77%

%B0.56

Donchian pos99.96%

Donchian high25.45

Donchian low0.0000

AVWAP (52w high)25.31

vs AVWAP high+0.52%

AVWAP (52w low)25.33

vs AVWAP low+0.44%

OBV trendUp

Chaikin MF (20)-0.24

Today vs 20d0.76×

Avg vol (14d)5.34K

Avg vol (20d)4.7K

Avg $ vol (20d)119.13K

Market cap319.04M

RS 3m (vs SPY)-12.14%

RS 6m (vs SPY)-8.32%

RS line new highNo

Trend template4/8

Technical rank51.1

1 week+0.16%

1 month+0.45%

3 months+0.12%

6 months-0.59%

1 year+0.55%

YTD+0.63%

P/E10.06

P/B3.44

P/S30.83

P/FCF111.91

EPS1.46

Div yield1.72%

ROE34.14%

ROA11.66%

Debt/Eq1.11

Current3.59

EV/EBITDA29.46

Gross margin—

Net margin306.40%

Rev growth55.64%

EPS growth329.45%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value336.28M

Revenue225K

Net income4.46M

Gross profit—

Free cash flow2.85M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out1.6M

Employees14

ListedMon, Apr 12, 2021

Free float6.6M

Float %52.6%

Short interest2.15K

Days to cover0.5d

Short volume27.4%

Squeeze score2 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction27 / 100

Pattern quality—

Tech rank51.1 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance25.42

Support12.58

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in XOMAO

All disclosures →

No recent disclosed trades by Congress in XOMAO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in XOMAO

No recent insider (Form 4) filings in XOMAO. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in XOMAO

EDGAR →

No recent SEC filings on file for XOMAO.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.